{"id":"https://openalex.org/W2886423465","doi":"https://doi.org/10.1158/1538-7445.am2018-5804","title":"Abstract 5804: A novel copper(II) complex of tolfenamic acid exhibits anticancer activity in pancreatic cancer cells via downregulation of transcription factors Sp1 and Sp3 and an anti-apoptotic protein, survivin","display_name":"Abstract 5804: A novel copper(II) complex of tolfenamic acid exhibits anticancer activity in pancreatic cancer cells via downregulation of transcription factors Sp1 and Sp3 and an anti-apoptotic protein, survivin","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2886423465","doi":"https://doi.org/10.1158/1538-7445.am2018-5804","mag":"2886423465"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-5804","doi":"https://doi.org/10.1158/1538-7445.am2018-5804","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-5804","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026504263","display_name":"Myrna Hurtado","orcid":"https://orcid.org/0000-0003-0704-8384","observed_orcids":["https://orcid.org/0000-0003-0704-8384"]},"institutions":[{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myrna L. Hurtado","raw_affiliation_strings":["1University of North Texas Health Science Center, Fort Worth, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Texas Health Science Center, Fort Worth, TX;","institution_ids":["https://openalex.org/I165139151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041786738","display_name":"Umesh T. Sankpal","orcid":"https://orcid.org/0000-0001-6696-2315","observed_orcids":["https://orcid.org/0000-0001-6696-2315"]},"institutions":[{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umesh T. Sankpal","raw_affiliation_strings":["1University of North Texas Health Science Center, Fort Worth, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Texas Health Science Center, Fort Worth, TX;","institution_ids":["https://openalex.org/I165139151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069454440","display_name":"Shahela Mahammad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahela Mahammad","raw_affiliation_strings":["1University of North Texas Health Science Center, Fort Worth, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Texas Health Science Center, Fort Worth, TX;","institution_ids":["https://openalex.org/I165139151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048599521","display_name":"Jaya Chhabra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I81365321","display_name":"Old Dominion University","ror":"https://ror.org/04zjtrb98","country_code":"US","type":"education","lineage":["https://openalex.org/I81365321"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaya Chhabra","raw_affiliation_strings":["2Old Dominion University, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Old Dominion University, Norfolk, VA","institution_ids":["https://openalex.org/I81365321"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065647241","display_name":"Deondra T. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I81365321","display_name":"Old Dominion University","ror":"https://ror.org/04zjtrb98","country_code":"US","type":"education","lineage":["https://openalex.org/I81365321"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deondra K. Brown","raw_affiliation_strings":["2Old Dominion University, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Old Dominion University, Norfolk, VA","institution_ids":["https://openalex.org/I81365321"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070867508","display_name":"Raj K. Gurung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I81365321","display_name":"Old Dominion University","ror":"https://ror.org/04zjtrb98","country_code":"US","type":"education","lineage":["https://openalex.org/I81365321"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raj K. Gurung","raw_affiliation_strings":["2Old Dominion University, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Old Dominion University, Norfolk, VA","institution_ids":["https://openalex.org/I81365321"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088156747","display_name":"Alvin A. Holder","orcid":"https://orcid.org/0000-0001-9618-5297","observed_orcids":["https://orcid.org/0000-0001-9618-5297"]},"institutions":[{"id":"https://openalex.org/I81365321","display_name":"Old Dominion University","ror":"https://ror.org/04zjtrb98","country_code":"US","type":"education","lineage":["https://openalex.org/I81365321"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alvin Holder","raw_affiliation_strings":["2Old Dominion University, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Old Dominion University, Norfolk, VA","institution_ids":["https://openalex.org/I81365321"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007695569","display_name":"Riyaz M. Basha","orcid":"https://orcid.org/0000-0002-4071-0993","observed_orcids":["https://orcid.org/0000-0002-4071-0993","https://orcid.org/0000-0002-6955-5448"]},"institutions":[{"id":"https://openalex.org/I165139151","display_name":"University of North Texas Health Science Center","ror":"https://ror.org/05msxaq47","country_code":"US","type":"education","lineage":["https://openalex.org/I165139151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Riyaz Basha","raw_affiliation_strings":["1University of North Texas Health Science Center, Fort Worth, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of North Texas Health Science Center, Fort Worth, TX;","institution_ids":["https://openalex.org/I165139151"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"5804","last_page":"5804"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cu-ii-complexes","display_name":"copper(II) complexes","score":0.9559999704360962},{"id":"https://openalex.org/keywords/tolfenamic-acid","display_name":"tolfenamic acid","score":1.0},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/sp1","display_name":"Sp1","score":0.75},{"id":"https://openalex.org/keywords/sp3","display_name":"Sp3","score":0.9990000128746033},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/transcription-factors","display_name":"transcription factors","score":0.6570000052452087},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7239999771118164},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.5389999747276306},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.8019999861717224},{"id":"https://openalex.org/keywords/mia-paca-2-cells","display_name":"MIA PaCa-2 cells","score":0.8389999866485596},{"id":"https://openalex.org/keywords/panc1","display_name":"Panc1","score":0.8960000276565552},{"id":"https://openalex.org/keywords/metal-based-anticancer-agents","display_name":"metal-based anticancer agents","score":0.5740000009536743},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.503000020980835},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.4169999957084656},{"id":"https://openalex.org/keywords/h9c2-cells","display_name":"H9c2 cells","score":0.7009999752044678},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C2775975398","wikidata":"https://www.wikidata.org/wiki/Q906904","display_name":"Survivin","level":3,"score":0.919223427772522},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6697614789009094},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5602115392684937},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.5180835723876953},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4920494258403778},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46732297539711},{"id":"https://openalex.org/C2777408456","wikidata":"https://www.wikidata.org/wiki/Q174299","display_name":"Inhibitor of apoptosis","level":4,"score":0.4570181667804718},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4502061903476715},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41497641801834106},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39573267102241516},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3370479941368103},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3173907399177551},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26182758808135986},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21628445386886597},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07959601283073425}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-5804","doi":"https://doi.org/10.1158/1538-7445.am2018-5804","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-5804","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2605653536","https://openalex.org/W2741093502","https://openalex.org/W2903468426","https://openalex.org/W2807602776","https://openalex.org/W2991365718","https://openalex.org/W1866744170","https://openalex.org/W2946801038","https://openalex.org/W2954902550","https://openalex.org/W2153107561","https://openalex.org/W4409690527"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"advances":[2],"in":[3,64,130,145,150,227,315,464],"research,":[4],"pancreatic":[5,465],"cancer":[6,466],"(PC)":[7],"remains":[8],"one":[9],"of":[10,46,102,113,147,175,179,230,297,343,423,458,470,484],"the":[11,44,76,172,193,224,228,237,243,340,380,384,420,485],"most":[12],"lethal":[13],"malignancies.":[14],"The":[15],"five-year":[16],"survival":[17],"rate":[18],"is":[19,31,52,72,208,240,405],"8%":[20],"and":[21,82,87,95,139,168,233,249,256,261,274,277,282,301,308,319,336,345,354,366,389,410,474,476],"standard":[22],"treatment":[23,45],"options":[24],"often":[25],"cause":[26,393],"high":[27],"toxicity.":[28],"Thus,":[29],"there":[30],"a":[32,53,110,118,142,204,214,247,360],"pressing":[33],"need":[34],"for":[35,43,413,488],"identifying":[36],"less":[37],"toxic":[38],"yet":[39,126],"more":[40,406],"effective":[41,314,407],"agents":[42],"this":[47],"malignancy.":[48],"Tolfenamic":[49],"acid":[50,460],"(TA)":[51],"NSAID":[54],"used":[55,161,226],"as":[56,211,213,246],"migraine":[57],"medicine":[58],"but":[59],"has":[60,106,125],"recently":[61],"been":[62,107],"demonstrated":[63,383],"pre-clinical":[65],"studies":[66],"to":[67,74,127,170,188,235,242,267,397,417],"have":[68],"anti-cancer":[69,238],"properties.":[70],"It":[71],"known":[73],"downregulate":[75],"transcription":[77,471],"factor":[78],"Specificity":[79],"protein":[80,276,321],"1":[81],"3":[83],"(Sp1,":[84],"Sp3).":[85],"Sp1":[86,344,365,473],"Sp3":[88,273,318,346,367,475],"regulate":[89],"several":[90],"genes":[91],"involved":[92],"with":[93,198,223,294],"apoptosis":[94],"cell":[96,148,164,250,302],"growth,":[97],"including":[98],"survivin,":[99],"an":[100,156,477],"inhibitor":[101],"apoptosis.":[103],"Recently,":[104],"it":[105],"suggested":[108],"that":[109,136,207,326,351,403],"copper(II)":[111,456],"complex":[112,457],"TA":[114,138,300,337,355,390,409],"(Cu-TA)":[115],"can":[116],"produce":[117],"higher":[119],"therapeutic":[120,173],"response;":[121],"however,":[122,153,339],"its":[123],"efficacy":[124,174],"be":[128,357],"tested":[129],"gastro-intestinal":[131],"cancers.":[132],"Previously":[133],"we":[134,160],"presented":[135],"both":[137,334,352],"Cu-TA":[140,154,180,199,231,244,298,311,335,353,388,404,424],"caused":[141],"dose-dependent":[143],"response":[144],"inhibition":[146],"growth":[149],"PC":[151,163,414],"cells,":[152],"had":[155],"enhanced":[157],"effect.":[158],"Here,":[159],"human":[162],"lines":[165],"(MIA":[166],"PaCa-2":[167],"Panc1)":[169],"evaluate":[171,287],"Cu-TA.":[176],"Physical":[177],"characterization":[178],"was":[181,200,252,265,304,312,330],"performed":[182],"using":[183,203],"Fourier-transform":[184],"infrared":[185],"spectroscopy":[186],"(FTIR)":[187],"analyze":[189],"purity.":[190],"To":[191,286],"demonstrate":[192],"compound's":[194,385],"stability,":[195],"dose":[196,381],"curve":[197],"carried":[201],"out":[202],"stock":[205,217],"solution":[206],"one-year":[209],"old":[210,216],"well":[212],"6-month":[215],"solution.":[218],"Cells":[219],"were":[220,292],"also":[221],"treated":[222,293],"components":[225],"formation":[229],"(CuCl2":[232],"BPY)":[234],"ensure":[236],"activity":[239,463],"due":[241],"compound":[245],"whole":[248],"viability":[251,303],"measured":[253,305],"at":[254,280,306],"24":[255,281,307],"48":[257,283,309],"h.":[258,310],"Western":[259],"blot":[260],"quantitative":[262],"PCR":[263],"(qPCR)":[264],"done":[266],"assess":[268],"Cu-TA's":[269,376],"effect":[270],"on":[271],"Sp1,":[272,317],"survivin":[275,320,327,480],"mRNA":[278,328,341],"levels":[279],"h":[284],"post-treatment.":[285],"potential":[288],"cardiotoxicity,":[289],"cardiomyocytes":[290],"(H9C2)":[291],"increasing":[295],"dosages":[296],"or":[299],"highly":[313],"suppressing":[316],"expression.":[322],"qPCR":[323],"results":[324,374,401],"showed":[325],"expression":[329,342],"significantly":[331],"lower":[332],"following":[333],"treatment;":[338],"remained":[347],"unaltered.":[348],"This":[349],"suggests":[350],"could":[356],"working":[358],"through":[359,428],"similar":[361],"mechanism":[362],"by":[363,370],"effecting":[364],"post-translationally,":[368],"possibly":[369],"proteasome-dependent":[371],"degradation.":[372],"FTIR":[373],"confirmed":[375],"purity":[377],"(>99%)":[378],"while":[379],"curves":[382],"stability.":[386],"Both":[387],"did":[391],"not":[392],"any":[394],"significant":[395],"cytotoxicity":[396],"H9C2":[398],"cells.":[399],"These":[400],"show":[402],"than":[408],"potentially":[411],"useful":[412],"treatment.":[415],"Studies":[416],"precisely":[418],"understand":[419],"underlying":[421],"mechanisms":[422],"are":[425],"under":[426],"investigation":[427],"molecular":[429],"profiling":[430],"analysis.":[431],"Citation":[432],"Format:":[433],"Myrna":[434],"L.":[435],"Hurtado,":[436],"Umesh":[437],"T.":[438],"Sankpal,":[439],"Shahela":[440],"Mahammad,":[441],"Jaya":[442],"Chhabra,":[443],"Deondra":[444],"K.":[445,448],"Brown,":[446],"Raj":[447],"Gurung,":[449],"Alvin":[450],"Holder,":[451],"Riyaz":[452],"Basha.":[453],"A":[454],"novel":[455],"tolfenamic":[459],"exhibits":[461],"anticancer":[462],"cells":[467],"via":[468],"downregulation":[469],"factors":[472],"anti-apoptotic":[478],"protein,":[479],"[abstract].":[481],"In:":[482],"Proceedings":[483],"American":[486],"Association":[487],"Cancer":[489,502],"Research":[490],"Annual":[491],"Meeting":[492],"2018;":[493],"2018":[494],"Apr":[495],"14-18;":[496],"Chicago,":[497],"IL.":[498],"Philadelphia":[499],"(PA):":[500],"AACR;":[501],"Res":[503],"2018;78(13":[504],"Suppl):Abstract":[505],"nr":[506],"5804.":[507]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2018-08-22T00:00:00"}